Systemic Inflammatory Predictors of In-Hospital Mortality in COVID-19 Patients: A Retrospective Study
Authors:
- Bartosz KudlinskiBKBartosz Kudlinski
- Dominika ZgołaDZDominika Zgoła
- Marta StolińskaMSMarta Stolińska
- Magdalena MurkosMMMagdalena Murkos
- Jagoda KaniaJKJagoda Kania
- Pawel NowakPNPawel Nowak
- Anna NogaANAnna Noga
- Magdalena WojciechMWMagdalena Wojciech
- Gabriel ZaborniakGZGabriel Zaborniak
- Agnieszka Zembron-LacnyAZAgnieszka Zembron-Lacny
Open Access
- 30 March 2022
- journal article
- research article
- Published by MDPI AG in Diagnostics
- Vol. 12 (4) , 859
Abstract
The purpose of this study was to investigate whether routine blood tests and clinical characteristics can predict in-hospital mortality in COVID-19. Clinical data of 285 patients aged 59.7 ± 10.3 yrs. (males n = 189, females n = 96) were retrospectively collected from December 2020 to June 2021. Routine blood tests were recorded within the 1st hour of admission to hospital. The inflammatory variables, such as C-reactive protein (CRP), procalcitonin (PCT), neutrophils–lymphocyte ratio (NLR) and the systemic inflammatory index (SII), exceeded the reference values in all patients and were significantly higher in deceased patients (n = 108) compared to survivors (n = 177). The log-rank test for comparing two survival curves showed that patients aged ≥60.5 years, with PCT ≥ 0.188 ng/mL or NLR ≥ 11.57 103/µL were at a greater risk of death. NLR demonstrated a high impact on the COVID-19 mortality (HR 1.317; 95%CI 1.004–1.728; p < 0.05), whereas CRP and SII showed no effect (HR 1.000; 95%CI 1.000–1.004; p = 0.085 and HR 1.078; 95%CI 0.865–1.344; p = 0.503, respectively). In the first Polish study including COVID-19 patients, we demonstrated that age in relation to simple parameters derived from complete blood cell count has prognostic implications in the course of COVID-19 and can identify the patients at a higher risk of in-hospital mortality.Keywords
This publication has 63 references indexed in Scilit:
- Sex and Gender Differences in the Outcomes of Vaccination over the Life CourseAnnual Review of Cell and Developmental Biology, 2017
- How obesity affects the neutrophil/lymphocyte and platelet/lymphocyte ratio, systemic immune-inflammatory index and platelet indices: a retrospective study.2016
- Procalcitonin to guide antibiotic therapy in the ICUInternational Journal of Antimicrobial Agents, 2015
- Serum platelet, MPV, PCT and PDW values, neutrophil to lymphocyte and platelet to lymphocyte ratios in lung cancer diagnosis2015
- The Platelet-to-Lymphocyte Ratio Versus Neutrophil-to-Lymphocyte Ratio: Which is Better as a Prognostic Factor in Gastric Cancer?Annals of Surgical Oncology, 2015
- Usefulness of the Platelet-to-Lymphocyte Ratio in Predicting Angiographic Reflow After Primary Percutaneous Coronary Intervention in Patients With Acute ST-Segment Elevation Myocardial InfarctionThe American Journal of Cardiology, 2014
- Prognostic Role of Neutrophil-to-Lymphocyte Ratio in Solid Tumors: A Systematic Review and Meta-AnalysisJNCI: Journal of the National Cancer Institute, 2014
- Factors Contributing to Increased Platelet Reactivity in People With DiabetesDiabetes Care, 2009
- Platelets in inflammation and atherogenesisJournal of Clinical Investigation, 2005
- Procalcitonin as a marker of the systemic inflammatory response to infectionIntensive Care Medicine, 2000